Introduction {#s1}
============

Nonalcoholic fatty liver disease (NAFLD) affects almost a third of the adult population in North America [@pone.0065982-Browning1]. The clinical-histologic spectrum of NAFLD ranges from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) [@pone.0065982-NeuschwanderTetri1]. While NAFL progresses to cirrhosis in less than 5% of cases, NASH can progress to cirrhosis in 15--20% of cases [@pone.0065982-Adams1]--[@pone.0065982-Ekstedt1]. NAFLD is also a risk factor for the development of hepatocellular cancer which can develop with or without cirrhosis [@pone.0065982-Paradis1]. It is therefore a public health priority to better understand the pathogenesis of the disease as well as factors that drive disease progression.

Recently, a single variant in *PNPLA* (rs738409; I148M) has been shown to be strongly associated with increased hepatic fat levels, inflammation and fibrosis [@pone.0065982-Romeo1]--[@pone.0065982-Speliotes1]. Since the discovery of the association between the *PNPLA3* mutation and steatosis and steatohepatitis, several additional single nucleotide polymorphisms (SNPs) have been identified to be associated with NASH [@pone.0065982-Speliotes1]. However, despite these individual SNP associations, the biologic mechanisms that distinguish alternative clinical outcomes or disease progression are largely unknown.

Genetic analysis of biologic processes as opposed to analysis of individual SNPs may provide more insight into pathogenesis. The pathway of distinction analysis (PoDA) is a recently developed computational technique which tests for the association of variation within multiple genes involved in a defined biologic pathway with a given phenotype [@pone.0065982-Braun1]. This method may thus be used to investigate whether collections of constitutional genome variability within biologic processes determine the predisposition to develop steatohepatitis vs. steatosis or drive the progression to cirrhosis and hepatocellular cancer. Importantly, it identifies interactions between SNPs in driving a specific phenotype even when individually the SNPs may not be significantly related to the phenotype.

In this analysis, PoDA was performed on a genome wide association study dataset obtained from the NIDDK NASH Clinical Research Network (CRN) on 250 highly characterized adult female subjects with varying phenotypes of NAFLD [@pone.0065982-Chalasani1]. The specific objectives of the study were to determine whether biologic process variation measured through genomic variation of genes within these networks was related to the development of steatohepatitis or cirrhosis. We further evaluated the relationships of variation within these biological pathways with the severity of the individual histologic parameters of NAFLD. The results demonstrate the potential relationship of genomic variability within key biologic pathways that correlate with both the individual histologic features of NAFLD, the presence of steatohepatitis and progression to cirrhosis.

Materials and Methods {#s2}
=====================

The Population Studied {#s2a}
----------------------

The genome wide association study (GWAS) was conducted on 250 highly characterized adult subjects with varying phenotypes of NAFLD, a subset of patients who were enrolled into the NAFLD Database Study of NASH CRN [@pone.0065982-Chalasani1]. The database study was an observational cohort where no therapeutic interventions were undertaken. From this cohort, non-Hispanic, white, female adults were selected for the GWAS pilot study in order to reduce heterogeneity. The median age was 53 years (interquartile range: 46--60 years). The nature and clinical features of subjects in this cohort have also been published [@pone.0065982-NeuschwanderTetri1], [@pone.0065982-Chalasani1].

Single SNP association with the phenotype of NAFLD from this GWAS has already been published [@pone.0065982-Chalasani1]. This report represents an independent analysis of the GWAS dataset to identify genetic variations in biologic pathways associated with cirrhosis, NASH and the severity of the individual histologic features of NAFLD. The underlying assumption for the analysis was that inherited variations in genes in biologic pathways may determine the network functional status and thus the disease phenotype. The NAFLD Database study was approved by the IRB of each of the participating institutions of the NASH CRN. The GWAS was approved by the NASH CRN Steering Committee and was approved by the IRB at Cedars Sinai Medical Center, where the GWAS was performed. For each subject included in this analysis, detailed clinical information and data related to the liver histology was available. The histology was analyzed by the pathology committee of the NASH CRN and categorized using the NASH CRN scoring system as described previously [@pone.0065982-Kleiner1].

Genotyping {#s2b}
----------

Genotyping was performed with the use of Illumina HumanCNV370-Quadv3 BeadChips as described previously [@pone.0065982-Chalasani1] **.** Eight out of 250 samples were identified as outliers by principal component analysis (PCA) and were therefore removed with 242 samples remaining for the analysis. Additional filters applied to SNP data eliminated variants that did not show Hardy-Weinberg Equilibrium (P\<1e-008) and minor allele frequency \<0.02; resulting in a total of 324,623 SNPs for the analysis.

Data Analysis {#s2c}
-------------

The Pathway of Distinction Analysis (PoDA) [@pone.0065982-Braun1] was applied to the NAFLD genotype data for the following histologic phenotypes: steatohepatitis, NAFLD activity score (NAS) and its histologic components (steatosis, cytologic ballooning and lobular inflammation), fibrosis stage, and cirrhosis. Each of these phenotypes were analyzed as qualitative binary traits as described below: (1) Steatohepatitis: definite steatohepatitis (n = 56) vs. controls (steatohepatitis absent, n = 131). (2) NAS: high score (NAS ≥5, n = 114) vs. low scores (NAS \<5, n = 124), Steatosis: moderate to severe (grades 2--3, n = 102) vs. mild to none (grades \<2, n = 93), Lobular inflammation: moderate to severe (grades 2--3, n = 96) vs. mild to none (grades 0--1, n = 99), Ballooning: many ballooned cells (grade 2, n = 111) vs. controls with no ballooning (grade 0, n = 84). (3) Fibrosis stage (range 0--4): fibrosis (score ≥2, n = 130) and control (score \<2, n = 108). (4) Cirrhosis: cirrhosis (n = 35) vs. control (n = 204). The total number of samples analyzed is less than the full sample set because of incomplete clinical data on the cohort that does not allow a full analysis, and "n" reflects the total number of subjects on whom the detailed clinical, histological and GWAS data were available.

To assess the potential impact of population stratification generating non-disease related associations, the population was examined for all SNPs included in the analysis. Stratification analysis was performed on each of 7 phenotypes using Principal Component Analysis, which was implemented using singular value decomposition algorithm of R. No evidence of stratification was found in any of these 7 phenotypes used in the study.

The PoDA analysis was run systematically to the pathways represented in NCI/Nature Pathway Interaction Database (PID) [@pone.0065982-Schaefer1]. Associations between genes and SNPs were made using dbSNP build 129. A total of 95924 SNPs in the data could be associated with at least one of the pathways representing 4849 unique genes. The SNP showing the greatest magnitude of association with a given phenotype was selected to represent each gene for a given analysis. A total of 893 pathways were covered in the dataset with a minimum of 5 genes in each pathway. PoDA analysis tests for differences in variation between cases and controls by computing genetic distances based on the variation observed within and between each group. A distance score was computed in each pathway for each sample measuring that sample's distance to the remaining cases relative to its distance to the remaining controls for the collection of gene-based SNPs that constitute a given pathway. The distinction score (DS) quantifying the differential distributions of distance scores between cases and controls were then computed for each pathway. Significance \[p(DS)\] was assessed by resampling "dummy" pathways of the same length and computing the fraction of greater DS scores as described previously [@pone.0065982-Braun1]. Odds ratios \[O.R.\] were obtained by constructing a logistic regression model of case status as a function of S values which measures the sample's relative distance from the remaining ones. P-values were then adjusted for the multiplicity of pathways using FDR adjustment \[q(O.R.)\].

Results {#s3}
=======

The PoDA analysis was performed on the samples and SNPs that remained following the quality control processing of the original dataset from 250 subjects (see Materials and Methods for the details). The collections of SNPs in genes contained in Pathway Interaction Database (PID) [@pone.0065982-Schaefer1] were examined for association with the following histological features of NAFLD that were recorded from Central Pathology Review: diagnosis of definite steatohepatitis, presence of cirrhosis, stage of fibrosis, grade of steatosis, ballooning and inflammation, and the NAFLD activity score (NAS) which is derived from the grade scores for ballooning, lobular inflammation, and steatosis. These histological parameters were either categorized to be absent or present; the severity of histological features that were scored was analyzed as a binary score as described in the Materials and methods section.

Biologic Pathways Associated with Definite Steatohepatitis {#s3a}
----------------------------------------------------------

Several pathways contained collections of SNPs that when examined simultaneously within the pathway were significantly associated with the histologic diagnosis of "definite steatohepatitis" ([Table 1](#pone-0065982-t001){ref-type="table"}). The top two pathways were "Viral messenger RNA synthesis" and "Recycling of eIF2:GDP" (p(DS) values \<0.001, and FDR adjusted odds ratio p-values of \<0.01). Several biosynthesis pathways, such as "Terpenoid biosynthesis", "Cholesterol biosynthesis", "Pyrimidine biosynthesis", "Biosynthesis of steroids", "O-Glycan biosynthesis", and "Bile acid biosynthesis", were also significantly associated with the diagnosis of definite steatohepatitis. The SNP collection in Cell cycle and p53 signaling pathways were also found to be associated with the diagnosis of steatohepatitis. The scatter plots of distance scores for two representative pathways are provided in [Figure 1](#pone-0065982-g001){ref-type="fig"}. The gene-based variations in two pathways previously associated with HCC in a large Korean cohort [@pone.0065982-Braun1], "Gamma-carboxylation, transport, and amino-terminal cleavage of proteins" and "Antigen processing and presentation", were also associated with the diagnosis of definite steatohepatitis (p(DS) values = 0.034 and 0.037, respectively, with both showing FDR odds ratio adjusted p-values \<0.01).

![Two representative significant pathways in steatohepatitis.\
Scatter plots of distance score S for each pathway and overlayed with boxplots are given in the left panel; higher values of S indicate the sample is closer to other cases than it is to other controls. Distribution of S for cases (red) and controls (black) are given to the right. **A.** "Viral messenger RNA synthesis" -- Reactome. **B.** "mRNA splicing -- Major pathway" -- Reactome.](pone.0065982.g001){#pone-0065982-g001}
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###### Pathways significantly associated with NASH diagnosis.

![](pone.0065982.t001){#pone-0065982-t001-1}

  Pathway                                                                                   Source     No. of genesin pathway   No. of SNPsin pathway   p(DS)   O.R.   q(O.R.)    Significantin HCC
  -------------------------------------------------------------------------------------- ------------ ------------------------ ----------------------- ------- ------ ---------- -------------------
  Viral Messenger RNA Synthesis                                                            Reactome              65                      46             0.000   \>10   2.51E-06  
  Recycling of eIF2:GDP                                                                    Reactome              8                        5             0.000   2.58   6.11E-03  
  mRNA Splicing - Major Pathway                                                            Reactome             106                      79             0.002   \>10   2.63E-07  
  Elongation of Intron-Containing Transcripts and co-transcriptional mRNA splicing         Reactome              44                      37             0.002   \>10   1.11E-05  
  Cell cycle                                                                                 KEGG                82                      64             0.003   \>10   8.51E-09  
  Terpenoid biosynthesis                                                                     KEGG                6                        6             0.003   4.73   4.22E-04  
  p53 signaling pathway                                                                    BioCarta              13                      12             0.004   \>10   3.33E-05  
  Leading Strand Synthesis                                                                 Reactome              9                        6             0.004   4.50   2.05E-03  
  inhibition of matrix metalloproteinases                                                  BioCarta              8                        7             0.006   7.30   2.65E-04  
  Ethanol is oxidized by NAD+ to form acetaldehyde, NADH, and H+                           Reactome              6                        6             0.007   1.88   2.04E-03  
  cell cycle: g2/m checkpoint                                                              BioCarta              23                      18             0.009   \>10   1.42E-06  
  regulation of transcriptional activity by pml                                            BioCarta              12                      10             0.010   \>10   1.25E-05  
  Cholesterol biosynthesis                                                                 Reactome              8                        8             0.012   \>10   4.52E-05  
  regulation of eif2                                                                       BioCarta              11                       9             0.013   9.83   1.44E-04  
  Telomere C-strand (Lagging Strand) Synthesis                                             Reactome              9                        6             0.014   4.50   2.05E-03  
  Folding of actin by CCT/TriC                                                             Reactome              10                       9             0.015   4.31   5.98E-03  
  Toll Like Receptor 4 (TLR4) Cascade                                                      Reactome              6                        6             0.016   3.39   1.58E-03  
  Lagging Strand Synthesis                                                                 Reactome              9                        6             0.016   4.50   2.05E-03  
  RNA Polymerase III Transcription Termination                                             Reactome              16                      12             0.016   \>10   1.53E-05  
  Mitochondrial tRNA aminoacylation                                                        Reactome              21                      18             0.017   \>10   1.16E-05  
  Direct p53 effectors                                                                    NCI-Nature            139                      117            0.022   \>10   8.51E-09  
  Pyrimidine biosynthesis (interconversion)                                                Reactome              11                       7             0.022   3.50   1.29E-02  
  Biosynthesis of steroids                                                                   KEGG                23                      21             0.023   \>10   8.69E-05  
  DNA strand elongation                                                                    Reactome              9                        6             0.023   4.50   2.05E-03  
  Regulation of CDC42 activity                                                            NCI-Nature             30                      21             0.024   \>10   1.18E-06  
  mitochondrial fatty acid beta-oxidation of unsaturated fatty acids                       Reactome              6                        5             0.028   2.00   4.20E-03  
  Processing of Capped Intron-Containing Pre-mRNA                                          Reactome              35                      30             0.028   \>10   4.06E-05  
  Aurora B signaling                                                                      NCI-Nature             42                      36             0.028   \>10   8.69E-06  
  eukaryotic protein translation                                                           BioCarta              20                      13             0.029   8.75   2.05E-03  
  O-Glycan biosynthesis                                                                      KEGG                30                      26             0.029   \>10   6.89E-08  
  the prc2 complex sets long-term gene silencing through modification of histone tails     BioCarta              14                      11             0.031   \>10   7.00E-05  
  Bile acid biosynthesis                                                                     KEGG                31                      29             0.032   \>10   1.95E-05  
  Regulation of retinoblastoma protein                                                    NCI-Nature             65                      57             0.033   \>10   1.42E-07  
  E2F transcription factor network                                                        NCI-Nature             72                      57             0.033   \>10   4.11E-07  
  Gamma-carboxylation, transport, and amino-terminal cleavage of proteins                  Reactome              8                        6             0.034   2.62   9.75E-03          yes
  Trafficking of AMPA receptors                                                            Reactome              5                        5             0.034   1.14   3.41E-01  
  Phosphorylation of CD3 and TCR zeta chains                                               Reactome              8                        5             0.034   4.30   2.02E-04  
  Antigen processing and presentation                                                        KEGG                64                      38             0.037   \>10   1.22E-05          yes
  Hemostasis                                                                               Reactome              5                        5             0.040   \>10   2.92E-08  
  Prostate cancer                                                                            KEGG                80                      67             0.040   3.10   1.28E-03  
  deregulation of cdk5 in alzheimers disease                                               BioCarta              7                        7             0.040   3.72   1.94E-03  
  Processive synthesis on the C-strand of the telomere                                     Reactome              6                        5             0.043   2.57   7.36E-03  
  Electron Transport Chain                                                                 Reactome              66                      48             0.043   \>10   4.67E-06  
  BARD1 signaling events                                                                  NCI-Nature             29                      27             0.044   \>10   1.59E-05  
  cyclins and cell cycle regulation                                                        BioCarta              23                      20             0.045   \>10   2.84E-05  
  1- and 2-Methylnaphthalene degradation                                                     KEGG                13                      12             0.046   3.70   2.15E-03  
  Aminoacyl-tRNA biosynthesis                                                                KEGG                39                      33             0.048   \>10   6.02E-06  
  trefoil factors initiate mucosal healing                                                 BioCarta              37                      31             0.048   \>10   2.37E-06  
  Nectin adhesion pathway                                                                 NCI-Nature             28                      28             0.049   \>10   8.58E-07  

Note: Pathway-length based resampled p-values, denoted as p(DS), are given for significant pathways (p\<0.05), along with odds ratios and associated FDRs for a logistic regression model. The pathways previously shown to be associated with HCC are marked.

Biologic Pathways Associated with Histologic Activity of NAFLD {#s3b}
--------------------------------------------------------------

We next investigated the relationship between pathway-based SNPs with NAS, and its independent components: steatosis, lobular inflammation and ballooning [@pone.0065982-Kleiner1]. For this analysis, a NAS score ≥5 was used to identify high disease activity. A high NAS was associated with the SNP variants in "Glycoprotein hormones" (p(DS) value\<0.001, FDR odds ratio adjusted p-value\<0.01, [Table S1](#pone.0065982.s001){ref-type="supplementary-material"}). Interestingly there were multiple cancer pathways associated with NAS including "Colorectal cancer" (p(DS) = 0.002, FDR odds ratio adjusted p-value\<0.01), "Renal cell carcinoma" (p(DS) = 0.011, FDR odds ratio adjusted p-value\<0.01), "Pathways in cancer" (p(DS) = 0.021, FDR odds ratio adjusted p-value\<0.01), "Melanoma" (p(DS) = 0.038, FDR odds ratio adjusted p-value\<0.01), and "Acute myeloid leukemia" (p(DS) = 0.043, FDR odds ratio adjusted p-value\<0.01). Of note, these pathways were not shown to be significantly associated with the diagnosis of definite steatohepatitis. Four pathways "Vibrio cholerae infection", "Antigen processing and presentation", "no2-dependent il-12 pathway in nk cells" and "ErbB signaling pathway" previously described to be associated with HCC were also associated with a high NAS [@pone.0065982-Braun1].

The association of individual components of NAS with biologic pathways using a cutoff of p(DS) value\<0.001 was nxt examined. "Glycoprotein hormones" and "il12 and stat4 dependent signaling pathway in th1 development" were observed to be associated with steatosis ([Table S2](#pone.0065982.s002){ref-type="supplementary-material"}). Of the previously described SNP variants in pathways associated with HCC, only "growth hormone signaling pathway" was associated with steatosis (p(DS) value = 0.002, FDR odds ratio adjusted p-value\<0.01). "Hormone ligand-binding receptors" pathway was associated with lobular inflammation ([Table S3](#pone.0065982.s003){ref-type="supplementary-material"}) and "Terpenoid biosynthesis" was observed to be associated with ballooning ([Table S4](#pone.0065982.s004){ref-type="supplementary-material"}).

Pathways Associated with Advanced Fibrosis and Cirrhosis {#s3c}
--------------------------------------------------------

Analysis of fibrosis (stages 3--4 vs.0--2) showed that the top pathway that was associated with advanced fibrosis was the "p38 MAPK signaling pathway" (p(DS) value\<0.001, FDR odds ratio adjusted p-value\<0.01, [Table S5](#pone.0065982.s005){ref-type="supplementary-material"}). Two pathways "Galactose metabolism" and "Reelin signaling pathway" associated with HCC are also associated with fibrosis (p(DS) -values = 0.018 and 0.040 respectively, both with FDR odds ratio adjusted p-values \<0.01).

Extension of this analysis to cirrhosis versus absence of cirrhosis (Stage 4 fibrosis) identified several pathways that were associated with cirrhosis ([Table 2](#pone-0065982-t002){ref-type="table"}). Three pathways were observed to be associated with cirrhosis with a p(DS) value\<0.001, FDR odds ratio adjusted p-value\<0.01: "Il2 signaling events mediated by PI3K", "Mitotic metaphase/anaphase transition", and "Protanoid ligand receptors". The scatter plots of distance scores for two representative pathways are provided in [Figure 2](#pone-0065982-g002){ref-type="fig"}. Of note, these pathways were associated with the presence of cirrhosis but were not associated to fibrosis alone. The pathways "lectin induced complement pathway" and "signaling events mediated by stem cell factor (c-kit)" were also found to be associated with cirrhosis (p(DS) -values = 0.004 and 0.037, respectively, both with FDR odds ratio adjusted p-values \<0.01) in previous HCC analysis [@pone.0065982-Braun1].

![Two representative significant pathways in cirrhosis.\
Scatter plots of distance score S for each pathway and overlayed with boxplots are given in the left panel; higher values of S indicate the sample is close to other cases than it is to other controls. Distribution of S for cases (red) and controls (black) are given to the right. **A.** "IL2 signaling events mediated by PI3K" -- NCI-Nature. **B.** "Lectin induced complement pathway" -- BioCarta.](pone.0065982.g002){#pone-0065982-g002}

10.1371/journal.pone.0065982.t002

###### Pathways significantly associated with Cirrhosis.

![](pone.0065982.t002){#pone-0065982-t002-2}

  Pathway                                                               Source     No. of genes in pathway   No. of SNPs in pathway   p(DS)   O.R.   q(O.R.)    Significant in HCC
  ------------------------------------------------------------------ ------------ ------------------------- ------------------------ ------- ------ ---------- --------------------
  IL2 signaling events mediated by PI3K                               NCI-Nature             37                        31             0.000   \>10   2.09E-07  
  Mitotic Metaphase/Anaphase Transition                                Reactome               8                        5              0.000   \>10   1.64E-05  
  Prostanoid ligand receptors                                          Reactome               7                        5              0.000   3.17   9.81E-03  
  Recruitment of NuMA to mitotic centrosomes                           Reactome              11                        11             0.003   \>10   8.70E-05  
  COPI Mediated Transport                                              Reactome              10                        10             0.003   \>10   4.63E-04  
  lectin induced complement pathway                                    BioCarta              12                        12             0.004   \>10   3.84E-06          yes
  pertussis toxin-insensitive ccr5 signaling in macrophage             BioCarta               9                        9              0.005   \>10   1.20E-04  
  granzyme a mediated apoptosis pathway                                BioCarta              12                        9              0.006   6.77   3.53E-04  
  Synthesis of bile acids and bile salts via 27-hydroxycholesterol     Reactome               6                        5              0.006   5.50   9.25E-05  
  PDGFR-alpha signaling pathway                                       NCI-Nature             23                        16             0.008   \>10   3.75E-06  
  RNA Polymerase I Promoter Opening                                    Reactome              17                        12             0.008   6.21   2.14E-03  
  Exocytosis of Alpha granule                                          Reactome              41                        35             0.010   \>10   3.73E-06  
  Synthesis of bile acids and bile salts                               Reactome              10                        7              0.010   9.15   1.05E-04  
  EPO signaling pathway                                               NCI-Nature             34                        26             0.010   \>10   2.30E-06  
  Regulation of CDC42 activity                                        NCI-Nature             30                        21             0.010   \>10   7.12E-07  
  E-cadherin signaling in the nascent adherens junction               NCI-Nature             35                        33             0.013   \>10   9.55E-07  
  b cell survival pathway                                              BioCarta              13                        11             0.015   \>10   7.50E-05  
  Arf6 trafficking events                                             NCI-Nature             40                        35             0.017   \>10   6.72E-07  
  Recycling of eIF2:GDP                                                Reactome               8                        5              0.018   2.07   3.25E-02  
  role of mitochondria in apoptotic signaling                          BioCarta              13                        12             0.018   \>10   1.43E-04  
  Effects of Botulinum toxin                                          NCI-Nature             10                        9              0.021   \>10   2.04E-04  
  IL2 signaling events mediated by STAT5                              NCI-Nature             27                        20             0.021   \>10   8.10E-07  
  IL2-mediated signaling events                                       NCI-Nature             55                        48             0.023   \>10   2.09E-07  
  HDL-mediated lipid transport                                         Reactome               8                        7              0.023   9.22   1.93E-04  
  Caprolactam degradation                                                KEGG                 7                        6              0.024   5.43   1.02E-03  
  eukaryotic protein translation                                       BioCarta              20                        13             0.025   9.40   1.23E-03  
  Glycosphingolipid biosynthesis - lacto and neolacto series             KEGG                26                        22             0.028   \>10   7.59E-06  
  telomeres telomerase cellular aging and immortality                  BioCarta              15                        14             0.029   \>10   5.92E-05  
  Other semaphorin interactions                                        Reactome              14                        12             0.031   \>10   8.54E-06  
  Beta oxidation of hexanoyl-CoA to butanoyl-CoA                       Reactome               5                        5              0.034   1.79   3.21E-02  
  il22 soluble receptor signaling pathway                              BioCarta              11                        10             0.035   \>10   9.10E-04  
  C21-Steroid hormone metabolism                                         KEGG                10                        9              0.035   5.02   6.60E-03  
  Signaling events mediated by Stem cell factor receptor (c-Kit)      NCI-Nature             52                        42             0.037   \>10   1.31E-06          yes
  Beta oxidation of octanoyl-CoA to hexanoyl-CoA                       Reactome               5                        5              0.039   1.81   1.57E-02  
  Amino acid transport across the plasma membrane                      Reactome              29                        23             0.042   \>10   3.73E-06  
  p38 mapk signaling pathway                                           BioCarta              30                        24             0.042   \>10   8.18E-06  
  Nef Mediated CD4 Down-regulation                                     Reactome               7                        6              0.044   3.09   6.54E-03  
  Fatty acid biosynthesis                                                KEGG                 6                        6              0.046   2.38   3.55E-03  
  PDGFR-beta signaling pathway                                        NCI-Nature             54                        45             0.046   \>10   1.99E-07  
  Internalization of ErbB1                                            NCI-Nature             34                        31             0.047   \>10   1.78E-06  

Note: Pathway-length based resampled p-values, denoted as p(DS), are given for significant pathways (p\<0.05), along with odds ratios and associated FDRs for a logistic regression model. The pathways previously shown to be associated with HCC are marked.

Pathways Associated with Multiple Features of NAFLD {#s3d}
---------------------------------------------------

NAFLD covers a wide clinical-histologic spectrum, ranging from steatosis to NASH of varying grades of activity and stages of fibrosis. To facilitate the identification of components that contribute to composite phenotypes and to identify common underlying pathways across different liver histologic manifestations of NAFLD, the pathways significantly associated with 2 or more histologic features (p(DS) value\<0.05) are listed in [Table 3](#pone-0065982-t003){ref-type="table"} with their genes listed in [Table S6](#pone.0065982.s006){ref-type="supplementary-material"}. Not surprisingly, many pathways associated with steatosis, lobular inflammation or ballooning was also observed to be associated with NAS ≥5. With NAS ≥5 included, there are 4, 7 and 51 pathways associated with 4, 3 and 2 histological findings/scores respectively. The SNP variants in "Biosynthesis of steroids" and "Cholesterol biosynthesis" are associated with definite NASH, lobular inflammation, ballooning and the NAS; "Eukaryotic protein translation" was associated with definite NASH, ballooning, NAS and cirrhosis; "Terpenoid biosynthesis" was associated with definite NASH, lobular inflammation, ballooning and fibrosis. In addition, "Antigen processing and presentation" was associated with definite NASH and the NAS while "Recycling of eIF2:GDP" was associated with definite NASH, ballooning and cirrhosis.

10.1371/journal.pone.0065982.t003

###### Pathways significantly associated with 2 or more phenotypes.
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  pathway (p(DS) \<0.05)                                                                                                                                           Source     No. of genes in pathway   No. of SNPs in pathway   cirrhosis   fibrosis   nashdx   nas   steatosis   lobular   balloon   Significant in HCC   No. of phenotypes
  ------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------ ------------------------- ------------------------ ----------- ---------- -------- ----- ----------- --------- --------- -------------------- -------------------
  Biosynthesis of steroids                                                                                                                                          KEGG                23                        21                 0          0        yes     yes       0         yes       yes             0                    4
  Cholesterol biosynthesis                                                                                                                                        Reactome               8                        8                  0          0        yes     yes       0         yes       yes             0                    4
  eukaryotic protein translation                                                                                                                                  BioCarta              20                        13                yes         0        yes     yes       0          0        yes             0                    4
  Terpenoid biosynthesis                                                                                                                                            KEGG                 6                        6                  0         yes       yes      0        0         yes       yes             0                    4
  Antigen processing and presentation                                                                                                                               KEGG                64                        38                 0          0        yes     yes       0          0         0             yes                   3
  E2F transcription factor network                                                                                                                               NCI-Nature             72                        57                 0          0        yes     yes       0          0        yes             0                    3
  Ethanol is oxidized by NAD+ to form acetaldehyde, NADH, and H+                                                                                                  Reactome               6                        6                  0         yes       yes      0        0          0        yes             0                    3
  Glycoprotein hormones                                                                                                                                           Reactome               8                        7                  0          0         0      yes      yes        yes        0              0                    3
  Hormone ligand-binding receptors                                                                                                                                Reactome              11                        10                 0          0         0      yes      yes        yes        0              0                    3
  Pathogenic Escherichia coli infection                                                                                                                             KEGG                32                        27                 0          0         0      yes       0         yes       yes             0                    3
  Recycling of eIF2:GDP                                                                                                                                           Reactome               8                        5                 yes         0        yes      0        0          0        yes             0                    3
  1- and 2-Methylnaphthalene degradation                                                                                                                            KEGG                13                        12                                     yes                                   yes                                  2
  3-Chloroacrylic acid degradation                                                                                                                                  KEGG                13                        13                                                                 yes       yes                                  2
  angiotensin ii mediated activation of jnk pathway via pyk2 dependent signaling                                                                                  BioCarta              34                        28                                                      yes        yes                                            2
  B cell receptor signaling pathway                                                                                                                                 KEGG                58                        47                                             yes                 yes                                            2
  BARD1 signaling events                                                                                                                                         NCI-Nature             29                        27                                     yes                         yes                                            2
  Cell cycle                                                                                                                                                        KEGG                82                        64                                     yes                                   yes                                  2
  cell cycle: g2/m checkpoint                                                                                                                                     BioCarta              23                        18                                     yes                                   yes                                  2
  Cellular roles of Anthrax toxin                                                                                                                                NCI-Nature             22                        17                           yes                                             yes                                  2
  DNA strand elongation                                                                                                                                           Reactome               9                        6                                      yes                                   yes                                  2
  Elongation of Intron-Containing Transcripts and co-transcriptional mRNA splicing                                                                                Reactome              44                        37                                     yes                                   yes                                  2
  ErbB signaling pathway                                                                                                                                            KEGG                88                        75                                             yes                                          yes                   2
  Fatty acid biosynthesis                                                                                                                                           KEGG                 6                        6                 yes                                                        yes                                  2
  Folding of actin by CCT/TriC                                                                                                                                    Reactome              10                        9                                      yes                                   yes                                  2
  Galactose metabolism                                                                                                                                              KEGG                26                        22                           yes                                                            yes                   2
  Gamma-carboxylation, transport, and amino-terminal cleavage of proteins                                                                                         Reactome               8                        6                                      yes                                                  yes                   2
  Gluconeogenesis                                                                                                                                                 Reactome              15                        11                           yes                                             yes                                  2
  growth hormone signaling pathway                                                                                                                                BioCarta              22                        18                                                      yes                                 yes                   2
  inhibition of matrix metalloproteinases                                                                                                                         BioCarta               8                        7                                      yes                                   yes                                  2
  intrinsic prothrombin activation pathway                                                                                                                        BioCarta              23                        19                                             yes      yes                                                       2
  lectin induced complement pathway                                                                                                                               BioCarta              12                        12                yes                                                                       yes                   2
  links between pyk2 and map kinases                                                                                                                              BioCarta              26                        22                                                      yes        yes                                            2
  mitochondrial fatty acid beta-oxidation of unsaturated fatty acids                                                                                              Reactome               6                        5                                      yes                         yes                                            2
  mRNA Processing                                                                                                                                                 Reactome               9                        7                                                       yes        yes                                            2
  mRNA Splicing - Major Pathway                                                                                                                                   Reactome              106                       79                                     yes                                   yes                                  2
  Nef Mediated CD4 Down-regulation                                                                                                                                Reactome               7                        6                 yes                                                        yes                                  2
  Neuroactive ligand-receptor interaction                                                                                                                           KEGG                27                        23                                                      yes        yes                                            2
  Nicotinate metabolism                                                                                                                                           Reactome              12                        11                                                      yes        yes                                            2
  no2-dependent il-12 pathway in nk cells                                                                                                                         BioCarta               9                        8                                              yes                                          yes                   2
  nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells     BioCarta              15                        14                           yes                        yes                                                       2
  O-Glycan biosynthesis                                                                                                                                             KEGG                30                        26                                     yes              yes                                                       2
  p53 signaling pathway                                                                                                                                           BioCarta              13                        12                                     yes                                   yes                                  2
  pertussis toxin-insensitive ccr5 signaling in macrophage                                                                                                        BioCarta               9                        9                 yes                                   yes                                                       2
  Processing of Capped Intron-Containing Pre-mRNA                                                                                                                 Reactome              35                        30                                     yes                                   yes                                  2
  Reelin signaling pathway                                                                                                                                       NCI-Nature             29                        25                           yes                                                            yes                   2
  Regulation of CDC42 activity                                                                                                                                   NCI-Nature             30                        21                yes                  yes                                                                        2
  Regulation of gene expression in beta cells                                                                                                                     Reactome              11                        9                                                                  yes       yes                                  2
  Regulation of Insulin Secretion by Glucagon-like Peptide-1                                                                                                      Reactome              10                        9                                              yes                 yes                                            2
  Regulation of the Fanconi anemia pathway                                                                                                                        Reactome               8                        7                                              yes      yes                                                       2
  regulation of transcriptional activity by pml                                                                                                                   BioCarta              12                        10                           yes       yes                                                                        2
  regulators of bone mineralization                                                                                                                               BioCarta              11                        9                                              yes                           yes                                  2
  rho cell motility signaling pathway                                                                                                                             BioCarta              32                        28                                             yes                 yes                                            2
  role of nicotinic acetylcholine receptors in the regulation of apoptosis                                                                                        BioCarta              17                        14                           yes                                             yes                                  2
  Signaling events mediated by Stem cell factor receptor (c-Kit)                                                                                                 NCI-Nature             52                        42                yes                                                                       yes                   2
  Synthesis of bile acids and bile salts                                                                                                                          Reactome              10                        7                 yes                                                        yes                                  2
  Synthesis of bile acids and bile salts via 27-hydroxycholesterol                                                                                                Reactome               6                        5                 yes                                                        yes                                  2
  Telomere C-strand (Lagging Strand) Synthesis                                                                                                                    Reactome               9                        6                                      yes                                   yes                                  2
  Trafficking of AMPA receptors                                                                                                                                   Reactome               5                        5                                      yes     yes                                                                2
  trefoil factors initiate mucosal healing                                                                                                                        BioCarta              37                        31                                     yes                                   yes                                  2
  Vibrio cholerae infection                                                                                                                                         KEGG                47                        39                                             yes                                          yes                   2
  Viral Messenger RNA Synthesis                                                                                                                                   Reactome              65                        46                                     yes                                   yes                                  2
  Vitamins                                                                                                                                                        Reactome               6                        5                            yes                                   yes                                            2

Note: Pathways significantly associated with 2 or more histologic features (p(DS) value \<0.05) are listed along with histologic feature, no. of genes and snps in pathway.

Discussion {#s4}
==========

One approach to genetic analysis of complex diseases such as NAFLD is to stratify the characteristics of histology and identify the biologic mechanisms underpinning each. While recognizing that NAFLD represents an interaction between environmental, behavioral, and genetic factors, genetic analysis permits the identification of components that are modulated by the genetic makeup of the individual subject which is largely invariant over time. Recent GWAS and candidate-gene approaches are examples of this wherein a number of SNPs such as the *PNPLA3* have been identified that are associated with steatosis, steatohepatitis and more advanced disease [@pone.0065982-Speliotes1], [@pone.0065982-Sookoian1]. However, in the original publication from which the data is used for the current study has failed to identify any relationship between *PNPLA3* genetic variability and NAFLD, which may be a reflection of the modest sample size and highly select group of patients (non-Hispanic white female adults) [@pone.0065982-Chalasani1]. In the current study, *PNPLA3* exists in the pathway "1- and 2-Methylnaphthalene degradation", which is significantly associated with steatohepatitis and ballooning. Importantly, these studies have been able to de-link the relationship between insulin resistance and the hepatic histologic "phenotype" of NAFLD, indicating that genetic factors play an important role in determining the ultimate disease phenotype and outcomes of NAFLD.

The analysis performed here extends the genetic analysis concept by finding biologic pathways whose constitutional variations have the potential to stratify disease categories, underpin key subcomponents, and determine alternative clinical outcomes. Pragmatically, the PoDA method used here accomplishes this by incorporating the influence of SNPs that may not be significantly related to a disease phenotype individually but when present in combination with other such SNPs within a biologic network may be determinants of disease phenotype and outcomes [@pone.0065982-Braun1]. Our study identifies several novel pathways, and implicitly gene-based SNPs, that appear to be associated with the presence and severity of several features of steatohepatitis. These data are primarily applicable to non-Hispanic white females because of the sample selection for this pilot GWAS study, therefore the generalizability of the conclusions remains an open question.

Some of the key pathways linked to the presence of steatohepatitis and disease progression include those related to cholesterol synthesis and protein translation. These may be particularly germane given the central role of the liver in cholesterol homeostasis and the fundamental importance of regulation of protein translation to maintain cell viability. NASH is associated with accumulation of free cholesterol without a corresponding increase in cholesterol esters [@pone.0065982-Puri1]. This has recently been shown to be due to SREBP-2 driven transcriptional upregulation of HMG CoA reductase the rate-limiting enzyme for cholesterol synthesis [@pone.0065982-Min1]. The upstream components of cholesterol synthesis are also components of the mevalonate pathway the only part of the terpenoid synthesis pathway that exists in humans [@pone.0065982-Pollier1]. Several subcomponents of the terpenoid pathway and the cholesterol biosynthetic pathway e.g. farnesyl- and geranyl pyrophosphates affect cell proliferation and apoptosis [@pone.0065982-Lane1]. The current studies provide additional evidence that genetic factors that may modulate the activity of these pathways may affect activation of cell injury and apoptotic pathways which drive the development of steatohepatitis.

Another cellular process that has been implicated in the development of NASH and its progression is the unfolded protein response (UPR) [@pone.0065982-Puri2]. Inhibition of protein translation via phosphorylation of eIF-2α is a key step that relieves endoplasmic reticulum stress and increased eIF-2α phosphorylation has been seen in subjects with NASH [@pone.0065982-Puri2]. Also, numerous microRNAs that are differentially activated in NASH target eiF-2α [@pone.0065982-Cheung1]. The identification of the protein translation pathway, of which eIF-2α is a key component, further corroborates the relevance of the protein translation machinery in the development of steatohepatitis and its progression to cirrhosis. It also indicates that susceptibility may be attributable to genetic variation within this pathway. Whether this occurs by altering miRNA expression and function, eIF structure and function or other mechanisms requires experimental elucidation.

It is also noteworthy that collections of SNPs in several cancer-related biological pathways were also identified to be related to disease activity. These pathways have several overlapping components including k-Ras, Wnt-β catenin and multiple kinases involved in pro-inflammatory and cell proliferative pathways [@pone.0065982-Tsukamoto1]--[@pone.0065982-Yanagitani1]. These findings underscore the importance of the molecular pathways involved in cell proliferation and inflammation in defining the histologic activity of NAFLD and the susceptibility of these pathways to the genetic background of the individual. It is well known that cirrhosis is a risk factor for hepatocellular cancer and NASH-related cirrhosis is no exception to that rule [@pone.0065982-Sanyal1]--[@pone.0065982-Ascha1]. Recently, hepatocellular cancer has been identified even in the absence of cirrhosis in subjects with NAFLD [@pone.0065982-Paradis1]. Our findings provide a rationale to further investigate the role of genetics in the development of HCC in such cases.

Conclusion {#s4a}
----------

NAFLD is a complex biological state with multiple histological phenotypes and varied progression to cirrhosis. While several genes have been identified to be associated with these phenotypes, this study identified additional biologic processes whose genetic variation may underpin alternative phenotypes and determine outcome. It identifies genetic variation in genes within pathways that while not significantly related to disease phenotype individually, in combination are related to the development of steatohepatitis (the aggressive form of NAFLD), disease activity as defined by liver histology and its progression to cirrhosis. It also identifies potential key cellular pathways that may define genetically susceptible individuals. Several of these pathways are already closely related to the pathogenesis of NASH and disease progression. Taken together, the results provide evidence for additional ways, beyond the effects of single SNPs, by which genetic factors might contribute to the susceptibility to develop a particular phenotype of NAFLD and then progress to cirrhosis. Further studies are warranted to explain potential important genetic roles of these biological processes in NAFLD.
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